Barclays Maintains Equal-Weight on Thermo Fisher Scientific, Lowers Price Target to $600
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Luke Sergott maintains an Equal-Weight rating on Thermo Fisher Scientific (NYSE:TMO) but lowers the price target from $615 to $600.
June 28, 2024 | 3:58 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays analyst Luke Sergott maintains an Equal-Weight rating on Thermo Fisher Scientific but lowers the price target from $615 to $600.
The lowered price target from $615 to $600 suggests a less optimistic outlook for Thermo Fisher Scientific, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100